Update on the use of systemic biologic agents in the treatment of noninfectious uveitis

S Pasadhika, JT Rosenbaum - Biologics: Targets and Therapy, 2014 - Taylor & Francis
Uveitis is one of the leading causes of blindness worldwide. Noninfectious uveitis may be
associated with other systemic conditions, such as human leukocyte antigen B27-related …

Autoimmune and autoinflammatory mechanisms in uveitis

RW Lee, LB Nicholson, HN Sen, CC Chan… - Seminars in …, 2014 - Springer
The eye, as currently viewed, is neither immunologically ignorant nor sequestered from the
systemic environment. The eye utilises distinct immunoregulatory mechanisms to preserve …

Pharmacotherapy for uveitis: current management and emerging therapy

RJ Barry, QD Nguyen, RW Lee, PI Murray… - Clinical …, 2014 - Taylor & Francis
Uveitis, a group of conditions characterized by intraocular inflammation, is a major cause of
sight loss in the working population. Most uveitis seen in Western countries is noninfectious …

Biologics in the treatment of uveitis

FR Imrie, AD Dick - Current opinion in ophthalmology, 2007 - journals.lww.com
Biologic therapies have increased the treatment options for sight-threatening uveitis. Despite
experimental rationale, the lack of evidence from randomized controlled studies limits our …

Pathogenesis and current therapies for non-infectious uveitis

X Wu, M Tao, L Zhu, T Zhang, M Zhang - Clinical and Experimental …, 2023 - Springer
Non-infectious uveitis (NIU) is a disorder with various etiologies and is characterized by eye
inflammation, mainly affecting people of working age. An accurate diagnosis of NIU is crucial …

Interleukin‐1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives

G Lopalco, L Cantarini, A Vitale… - Mediators of …, 2015 - Wiley Online Library
A complex web of dynamic relationships between innate and adaptive immunity is now
evident for many autoinflammatory and autoimmune disorders, the first deriving from …

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics

AS Thomas - Current opinion in ophthalmology, 2019 - journals.lww.com
The TNF-α inhibitors adalimumab and infliximab have the greatest body of data supporting
their use in NIU. These agents are considered second-line therapy for most forms of NIU but …

Роль интерлейкина 1 в развитии заболеваний человека

ЕЛ Насонов, МС Елисеев - Научно-практическая ревматология, 2016 - cyberleninka.ru
Иммуновоспалительные заболевания человека в зависимости от преобладающих
механизмов активации иммунитета разделяются на две основные категории …

Interplay between innate and adaptive immunity in the development of non-infectious uveitis

F Willermain, JT Rosenbaum, B Bodaghi… - Progress in retinal and …, 2012 - Elsevier
In vertebrates, the innate and adaptive immune systems have evolved seamlessly to protect
the host by rapidly responding to danger signals, eliminating pathogens and creating …

Ocular involvement in monogenic autoinflammatory disease

I Maccora, E Marrani, MV Mastrolia… - Autoimmunity …, 2021 - Elsevier
Abstract Objective Monogenic Autoinflammatory diseases (AIDs) are a broad spectrum of
rare hereditary diseases whose ocular involvement has not been well characterized yet …